Premium
ANTIACTIVATOR IN PLASMA OF PATIENTS WITH BEHÇET'S DISEASE
Author(s) -
Tsushima Hirofumi,
Toki Naotika
Publication year - 1981
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.1981.tb02588.x
Subject(s) - behcet's disease , medicine , plasminogen activator , activator (genetics) , chemistry , endocrinology , disease , receptor
In the present study, it was confirmed for the first time that the plasminogen activator activity in the euglobulin fraction could be determined by the Testzym method using chromozyme S‐2251. Antiactivators in plasma of patients with Behçet's disease, who showed decreased blood fibrinolytic activity, could be precipitated together with the activator in the euglobulin fraction. It was confirmed that the antiactivator was inhibited by dextran sulfate.